The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb

Diabetic Medicine

Volumn 18, Issue 3, 2001, Pages 229-234

  Raymakers, J T ^a,d   Houben, A J ^b   Vd Heyden, J J ^c   Tordoir, J H ^a   Kitslaar, P J ^a   Schaper, N C ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Department of Internal Medicine ^*  (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d TWENTEBORG HOSPITAL   (Netherlands)

Author keywords

Antibiotic; Ceftazidime; Diabetic foot; Ischaemia; Penetration

Indexed keywords

CEFTAZIDIME;

AGED; ARTICLE; BONE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DRUG PENETRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIA; LIMB; MALE; MUSCLE; SKIN; TISSUE PERFUSION; TRANSCUTANEOUS OXYGEN MONITORING;

AGED; AMPUTATION; CEFTAZIDIME; CEPHALOSPORINS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; GANGRENE; HUMANS; ISCHEMIA; LEG; MALE; PERIPHERAL VASCULAR DISEASES; TISSUE DISTRIBUTION;

EID: 0035042752     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2001.00460.x     Document Type: Article

References (20)

1. Diabetic foot infections
2. Epidemiology
3. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections
4. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation ?
5. Antibiotic therapy in diabetic foot infection
6. Peripheral vascular disease and diabetes
7. The epidemiology of diabetic foot problems
8. Microvascular aspects of diabetic foot disease
9. Evidence-based antibiotic therapy of diabetic foot infections
10. Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy
11. The dysvascular foot: A system for diagnosis and treatment
12. The Vascular Laboratory
13. Penetration of ceftazidime into bone from severely ischemic limbs
14. The treatment of bone infections with ceftazidime
15. Is antibiotic penetration compromised in the ischemic tissues of patients undergoing amputation?
16. Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections
17. Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid
18. Pharmacokinetic study of ceftazidime in bone and serum of patients undergoing hip and knee arthroplasty
19. Cefamandole levels in serum and necrotic bone
20. Cefuroxime levels attained in tissues and wound exudates from severely ischemic limbs